Status:

RECRUITING

Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression

Lead Sponsor:

University of Texas, El Paso

Collaborating Sponsors:

University of California, San Francisco

Centro de Integracion Juvenil

Conditions:

HIV Viremia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study will test two behavioral intervention components to identify the combination of the two components that best supports people who inject drugs to achieve and sustain HIV viral load suppressio...

Detailed Description

Participants will be randomly assigned to one of 4 experimental conditions. Each condition will represents every possible combination of 2 components (e.g., 1 only, 2 only, 1-2, none). Participants co...

Eligibility Criteria

Inclusion

  • be at least 18 years of age
  • be able to provide informed consent
  • be eligible to receive free HIV care services in Mexico
  • be HIV positive
  • have injected drugs in the last 30 days
  • not be on methadone replacement therapy
  • be willing to discuss MAT uptake with a peer
  • sign a medical release form to have medical data abstracted
  • agree to submit and describe locator information
  • agree to return to follow-up visits
  • able to communicate in Spanish
  • screen positive for depression on the PHQ-2
  • have no plans of moving outside the study area in the next 12-months
  • meet one of the following:
  • not currently in possession of ART or not taking ART but prescribed ART or
  • sub-optimal ART adherence as at least one 4-day treatment interruption in the past 90 days or
  • sub-optimal retention in HIV care - never engaged or disengaged from HIV care as 2 or more missed clinic appointments in the last 9 months or
  • no viral load test done in the past six months or
  • self-reports a detectable viral load within the past 6 months

Exclusion

  • has not injected drugs in the last 30 days or do not have a verifiable opioid use disorder
  • is not HIV positive
  • is receiving methadone
  • is unwilling to discuss methadone uptake with a peer
  • does not screen positive for depression
  • is not able to provide informed consent
  • does not speak Spanish
  • has plans to move out of the city
  • does not qualify to receive free HIV care services in Mexico
  • has an appearance of psychological disturbance or severe cognitive impairment that could limit understanding of study procedures as determined by study staff

Key Trial Info

Start Date :

May 10 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2026

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT05377463

Start Date

May 10 2023

End Date

July 31 2026

Last Update

September 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Programa Compañeros

Ciudad Juárez, Chihuahua, Mexico, 32330